Aspirin analogues as dual cyclooxygenase-2/5-lipoxygenase inhibitors: synthesis, nitric oxide release, molecular modeling, and biological evaluation as anti-inflammatory agents.
ChemMedChem
; 7(1): 144-50, 2012 Jan 02.
Article
em En
| MEDLINE
| ID: mdl-22095955
ABSTRACT
Analogues of aspirin were synthesized through an efficient one-step reaction in which the carboxyl group was replaced by an ethyl ester, and/or the acetoxy group was replaced by an N-substituted sulfonamide (SO(2)NHOR(2)R(2) =H, Me, CH(2)Ph) pharmacophore. These analogues were designed for evaluation as dual cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) inhibitors. In vitro COX-1/COX-2 isozyme inhibition studies identified compounds 11 (CO(2) H, SO(2)NHOH), 12 (CO(2)H, SO(2)NHOCH(2)Ph), and 16 (CO(2)Et, SO(2)NHOH) as highly potent and selective COX-2 inhibitors (IC(50) range 0.07-0.7 µM), which exhibited appreciable in vivo anti-inflammatory activity (ED(50) range 23.1-31.4 mg kg(-1)). Moreover, compounds 11 (IC(50) =0.2 µM) and 16 (IC(50) =0.3 µM), with a sulfohydroxamic acid (SO(2)NHOH) moiety showed potent 5-LOX inhibitory activity. Furthermore, the SO(2)NHOH moiety present in compounds 11 and 16 was found to be a good nitric oxide (NO) donor upon incubation in phosphate buffer at pH 7.4. Molecular docking studies in the active binding site of COX-2 and 5-LOX provided complementary theoretical support for the experimental biological structure-activity data acquired.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Aspirina
/
Inibidores de Lipoxigenase
/
Inibidores de Ciclo-Oxigenase 2
/
Anti-Inflamatórios
Idioma:
En
Ano de publicação:
2012
Tipo de documento:
Article